Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Clin Rheumatol. 2008 Apr;14(2):92-3. doi: 10.1097/RHU.0b013e31816b4487.

Effect of rituximab on refractory Wegener granulomatosis with predominant granulomatous disease.

Author information

  • 1Unidad de Enfermedades Autoinmunes Sistémicas, Hospital Universitario San Cecilio, Granada, Spain. danifilax@gmail.com

Abstract

Wegener granulomatosis is an autoimmune disorder with a double spectrum. Vasculitic manifestations are at one end of it, whereas granulomatous ones are at the other. Rituximab (RTX) is a chimeric monoclonal antibody that has been successfully used in this condition. However, the granulomatous forms have been reported to show a tendency to be less responsive to RTX than the vasculitic disease. We present 4 cases of predominantly Wegener granulomatosis that responded positively to RTX.

Comment in

PMID:
18391678
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk